Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Long Covid's impact on daily activities of patients was worse than for stroke patients, as per research by UK experts.

Long Covid worse than cancer in hurting quality of life, says study

Long Covid's impact on daily activities of patients was worse than for stroke patients, as per research by UK experts.

People suffering from Long Covid have a lower quality of life regarding health than patients of some advanced cancers, according to a study conducted in the United Kingdom.
Health-related quality of life scores of Long Covid patients were lower than those of people with advanced metastatic cancers, like stage 4 lung cancer, as per a Guardian report quoting the study.
The impact of Long Covid on daily activities of patients was worse than for stroke patients and similar to people with Parkinson's disease, as per research by University College London and the University of Exeter.
Co-author of the study Prof William Henley said that Long Covid can leave people with worse fatigue than cancer, but support and understanding is not at the same level.

The study has found that coronavirus can produce severe and selective neuropsychological impairment similar to deficits seen following brain damage.

Study suggests long Covid-19 may cause Prosopagnosia; know more about this unusual condition

The study has found that coronavirus can produce severe and selective neuropsychological impairment similar to deficits seen following brain damage.

A latest study suggests that long Covid-19 may cause some people to develop face blindness. The study was published in the journal Cortex.&nbsp;
The study focused on an unusual case of a 28-year-old woman Annie, who got infected with corona virus in 2020 and two months later she struggled to identify her relatives, including her father when she passed across him at a restaurant.&nbsp;
For the uninitiated, face blindness is a condition in which a person finds it hard to recognise people's faces.&nbsp;
The study found out that coronavirus can produce severe and selective neuropsychological impairment similar to deficits seen following brain damage, and it appears that high-level visual impairments are not uncommon in people with long Covid.
Also Read: <a href="https://www.editorji.com/lifestyle-news/health/30-people-infected-with-coronavirus-develop-long-covid-study-reveals-1650618012041">30% people infected with coronavirus develop long Covid, study reveals</a>&nbsp;

Dr Anthony Fauci: long Covid represents an 'insidious' public health emergency 

Fauci said the cold fact that Covid-19 still kills 400 people a day in the US catches public attention more acutely than estimates of the millions suffering from long Covid.

America&rsquo;s top infectious disease expert Dr Anthony Fauci has warned against prematurely declaring victory over the pandemic and said that long Covid represents an &ldquo;insidious&rdquo; public health emergency for millions of people.
In an interview with the Guardian, Fauci urged US Congress to avoid complacency and resume funding to combat the virus as well as long Covid, a chronic and prolonged illness that continues to elude scientists and healthcare providers.
Fauci said the cold fact that Covid-19 still kills 400 people a day in the US catches public attention more acutely than estimates of the millions suffering from long Covid.
The World Health Organization believes that between 10% and 20% of Covid-19 survivors have been left with lasting symptoms including breathlessness, fatigue and cognitive dysfunction that can persist long after the acute infection has resolved.
Also Watch| <a href="https://www.editorji.com/coronavirus/astrazeneca-s-nasal-covid-vaccine-not-as-effective-as-expected-study-1665508372814">AstraZeneca&rsquo;s nasal Covid vaccine not as effective as expected: Study</a>

According to a recent US study, about 30% of COVID-19 patients develop long COVID.

Covid-19: 30% people infected with coronavirus develop long Covid, study reveals 

30% people infected with coronavirus develop long Covid, study reveals 

30% of Coronavirus&nbsp;patients develop long Covid
Researchers examined 1,038 Covid-19 patients
309 individuals developed long Covid
&nbsp;

According to a recent US study, about 30% of COVID-19 patients develop long COVID.

According to a recent study published in the General Internal Medicine journal, about 30% of COVID-19 patients develop the condition known as long COVID.
Also watch:&nbsp;<a href="https://www.editorji.com/lifestyle-news/health/does-mild-covid-19-affect-male-fertility-this-study-has-a-few-things-to-say-1649926451244">Does mild Covid-19 affect male fertility? This study has a few things to say</a>
For the study, UCLA researchers examined 1,038 Covid-19 patients between April 2020 and February 2021. While some had to be hospitalised, others were treated as outpatients.
As per the findings, 309 individuals developed long Covid and reported symptoms 60-90 days post-infection. While fatigue and shortness of breath were the most reported symptoms in hospitalised patients, outpatients reported the loss of smell the most.
Individuals with a history of hospitalisation, diabetes and a higher body mass index (BMI) are more likely to develop the condition, study authors concluded.
Also watch:<a href="https://www.editorji.com/lifestyle-news/health/here-s-why-pregnant-women-must-get-the-covid-19-vaccination-1643291881263">&nbsp;Here's why pregnant women must get the Covid-19 vaccination&nbsp;</a>

Covid-19 patients can face symptoms of the infection even a year after recovery, reveal the findings of a new Covid-19 study. 

After effects of Covid-19: Long covid symptoms can persist months post recovery

Covid-19 patients can face symptoms of the infection even a year after recovery, reveal the findings of a new Covid-19 study.

After effects of Covid-19: Symptoms can persist a year post recovery

Covid-19 symptoms can persist even a year after recovery: study
GFX PLATE 1
No proven&nbsp;treatment or guidance for Long Covid&nbsp;patients yet
Long Covid&nbsp;affects people's ability to work and resume normal life
GFX&nbsp;PLATE 2&nbsp;
1,300 Covid&nbsp;patients from China's Wuhan&nbsp;were observed in the study
GFX&nbsp;PLATE 3
GFX&nbsp;PLATE 4
Urgent need for better&nbsp;care&nbsp;and support from Long Covid patients

Patients of Covid-19 can&nbsp;face infection&nbsp;symptoms even&nbsp;a year after recovery, reveal the findings&nbsp;of&nbsp;a&nbsp;new&nbsp;Covid-19 study.&nbsp;

Patients of Covid-19 can face certain infection symptoms even a year after recovery, reveal the findings&nbsp;of&nbsp;a new study.&nbsp;&nbsp;
Published in the journal Lancet, the study found that&nbsp;at least one of the infection&rsquo;s&nbsp;symptoms,&nbsp;such as&nbsp;fatigue, muscle weakness or shortness of breath, troubled patients up to&nbsp;a&nbsp;year after being discharged from the hospital.
SEE MORE&nbsp;<a href="https://www.editorji.com/story/this-condition-might-be-causing-many-of-the-mysterious-long-covid-symptoms-1629797606071">This condition might be causing many of the mysterious Long Covid symptoms</a>
The researchers noted that since there is no proven treatment or guidance for the rehabilitation of patients,&nbsp;long Covid syndrome affects people's ability to resume normal life and their capacity to work. In fact, a complete recovery from Covid-19 may take more than 12 months for many.&nbsp;
The study assessed&nbsp;around&nbsp;1,300 people hospitalised for Covid-19 between January and May 2020 in&nbsp;China's Wuhan, the epicentre of the disease.&nbsp;The proportion of patients with at least one symptom decreased from 68% at 6 months to 49% at 12 months.&nbsp;&nbsp;
The same study also&nbsp;observed that&nbsp;respiratory discomfort increased from 26 per cent of patients after six months to 30 per cent after 12 months.&nbsp;&nbsp;
The researchers also recognized that 'Long Covid' is a modern challenge, so there is a need for better care&nbsp;and&nbsp;long term&nbsp;support of patients so that they can recover from the symptoms and return to a normal life.
SEE MORE&nbsp;<a href="https://www.editorji.com/story/what-are-the-aftereffects-of-covid-19-cognitive-problems-persist-months-later-1624621810173">What are the aftereffects of Covid-19? Cognitive problems persist months later&nbsp;</a>

Long Covid patients continue to have higher measures of blood clotting, which may be a cause for their persistent symptoms, such as reduced physical fitness and fatigue

LONG COVID: Blood clotting might be the cause of many Long Covid symptoms

This condition might be causing many of the mysterious Long Covid symptoms

A Covid&nbsp;negative report does not end the battle with the virus for many
Scientists are yet to discover a proper cure for Long Covid
New study points to a potential cause for the Long Covid&nbsp;syndrome
Higher measures of blood clotting may be causing&nbsp;persistent symptoms
Even when inflammation reduced, clotting potential remained high
Watch out for persistent symptoms Shortness of breath Chest pain Leg pain and swelling Constant abdominal pain
10% of all Covid&nbsp;patients face&nbsp;aftereffects: WHO;&nbsp;UK study says 30%
Understanding the cause is a crucial first step for developing treatment

Long Covid patients continue to have higher measures of blood clotting, which may be a cause for their persistent symptoms, such as reduced physical fitness and fatigue

Even after&nbsp;receiving the negative for the novel coronavirus report, the battle with Covid-related health problems is nowhere near over.&nbsp;And the race for a cure for these lingering after-effects&nbsp;of Covid-19, also known as Long Covid&nbsp;is yet to bear any fruits.
But a new study suggests a potential cause for the Long Covid syndrome.&nbsp;New evidence finds that Long Covid patients continue to have higher measures of blood clotting, which may be a cause for their persistent symptoms, such as reduced physical fitness and fatigue.
SEE MORE |&nbsp;<a href="https://www.editorji.com/story/older-women-at-greater-risk-of-long-covid-study-1603352715940">Older women at greater risk of 'long Covid': study</a>
Explaining the research, lead author&nbsp;Dr Helen Fogarty wrote that even&nbsp;when markers of inflammation&nbsp;returned to normal levels,&nbsp;increased clotting potential was still found to be present in Long Covid patients.&nbsp;
Experts have advised people with the post-Covid syndrome to watch out for&nbsp;persistent&nbsp;symptoms like&nbsp;shortness of breath, chest pain, leg pain and swelling, persistent abdominal pain&nbsp;and consult a doctor right away.&nbsp;
While it&nbsp;isn&rsquo;t clear how many people in the world are suffering from Long Covid, WHO says it&rsquo;s 10%&nbsp;of all Covid-19 patients&nbsp;while a UK study pegged it to be at&nbsp;least&nbsp;30%.&nbsp;&nbsp;For now, understanding the root cause of the&nbsp;disease&nbsp;is a crucial first step toward developing effective treatments.&nbsp;

The Indian government has commissioned a study to analyse the effects of the herb &lsquo;Ashwagandha&rsquo;, on people suffering from Long Covid.
A report by The Print says, the study is a joint project by the All-India Institute of Ayurveda (AIIA) and the London School of Hygiene and Tropical Medicine (LSHTM). 
It will be a year-long study and will be conducted on 2,000 people in Leicester, Birmingham, and London. The World Health Organisation is also a knowledge partner to the study. 
The participants will be required to take Ashwagandha for three months and the trials will start in late September. The study will be examine if the overall quality of life of the participants has improved after three months when compared to the placebo group. 
This will be the UK&rsquo;s first double-blind placebo-controlled trial of an Ayurvedic herb as a medicinal product.
Ashwagandha or Indian ginseng is an ancient medicinal herb and according to several research papers published, it is known to have anti-oxidant and anti-inflammatory properties and enhances brain function and increases the body&rsquo;s resilience to stress among other things. 

India, UK to conduct clinical trials of ‘Ashwagandha’ for Covid recovery in UK

The AYUSH&nbsp;Ministry has commissioned a study on the health benefits of Ashwagandha&nbsp;on people suffering from long Covid, click to know more

India commissions study to analyse effects of&nbsp;&lsquo;Ashwagandha&rsquo; in&nbsp;Covid recovery
A year-long study and will be conducted on 2,000 people across 3 UK cities
Participants will take Ashwagandha&nbsp;for 3 months and trial will start in September
Study will examine the overall quality of life of participants after 3 months&nbsp;
This&nbsp;is the UK&rsquo;s first double-blind placebo-controlled trial of an Ayurvedic herb
Ashwagandha&nbsp;is known for its anti-oxidant and anti-inflammatory properties

Initiated by Ministry of Ayush, the year-long study will assess if &lsquo;Ashwagandha&rsquo; alleviates symptoms of Long Covid among 2,000 candidates in three UK cities.

The Indian government has commissioned a study to analyse the effects of the herb &lsquo;Ashwagandha&rsquo;, on people suffering from Long Covid.
A report by The Print says, the study is a joint project by the All-India Institute of Ayurveda (AIIA) and the London School of Hygiene and Tropical Medicine (LSHTM).
It will be a year-long study and will be conducted on 2,000 people in Leicester, Birmingham, and London. The World Health Organisation is also a knowledge partner to the study.
The participants will be required to take Ashwagandha for three months and the trials will start in late September. The study will examine if the overall quality of life of the participants has improved after three months when compared to the placebo group.
This will be the UK&rsquo;s first double-blind placebo-controlled trial of an Ayurvedic herb as a medicinal product.
Ashwagandha or Indian ginseng is an ancient medicinal herb and according to several research papers published, it is known to have anti-oxidant and anti-inflammatory properties and enhances brain function and increases the body&rsquo;s resilience to stress among other things.
Also watch:&nbsp;<a href="https://www.editorji.com/story/ayurveda-for-covid-19-preventative-self-care-tips-from-ayush-ministry-1620472886286" target="_blank">Ayurveda for Covid-19: preventative self-care tips from AYUSH Ministry</a>

long covid

Categories